• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma.术前肿瘤标志物梯度对预测肝细胞癌微血管侵犯的意义
Mol Clin Oncol. 2020 Mar;12(3):290-294. doi: 10.3892/mco.2020.1975. Epub 2020 Jan 10.
2
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.术前甲胎蛋白和脱γ-羧基凝血酶原在肝细胞癌患者中的预后作用
World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933.
3
Clinical Significance of Preoperative Hepatocellular Carcinoma With High Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.术前甲胎蛋白凝集素反应性分数高但甲胎蛋白水平低的肝细胞癌的临床意义
Anticancer Res. 2019 Feb;39(2):883-889. doi: 10.21873/anticanres.13189.
4
Diagnostic value of prothrombin induced by the absence of vitamin K or antagonist-II (PIVKA-II) for early stage HBV related hepatocellular carcinoma.维生素K缺乏或拮抗剂-II诱导的凝血酶原(PIVKA-II)对早期HBV相关肝细胞癌的诊断价值
Infect Agent Cancer. 2017 Aug 23;12:47. doi: 10.1186/s13027-017-0153-6. eCollection 2017.
5
Diagnostic value of serum PIVKA-II levels for BCLC early hepatocellular carcinoma and correlation with HBV DNA.血清 PIVKA-II 水平对 BCLC 早期肝细胞癌的诊断价值及其与 HBV DNA 的相关性。
Cancer Biomark. 2018;23(2):235-242. doi: 10.3233/CBM-181402.
6
Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein.应用术前扁豆凝集素结合型甲胎蛋白预测肝癌根治性切除术后复发。
Hepatol Res. 2012 Sep;42(9):887-94. doi: 10.1111/j.1872-034X.2012.01004.x. Epub 2012 Apr 23.
7
Multiplication of alpha-fetoprotein and protein induced by vitamin K absence-II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy.甲胎蛋白与维生素K缺乏诱导蛋白-II的倍增是肝癌患者肝切除术后预后和复发的有力预测指标。
Hepatol Res. 2015 Oct;45(10):E21-31. doi: 10.1111/hepr.12451. Epub 2014 Dec 8.
8
Alpha-fetoprotein level to total tumor volume as a predictor of hepatocellular carcinoma recurrence after resection. A retrospective cohort study.甲胎蛋白水平与肿瘤总体积作为肝细胞癌切除术后复发预测指标的研究。一项回顾性队列研究。
Ann Med Surg (Lond). 2020 May 4;54:109-113. doi: 10.1016/j.amsu.2020.04.014. eCollection 2020 Jun.
9
Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.异常凝血酶原(PIVKA-II)在早期肝细胞癌诊断和微血管侵犯预测中的性能。
J Hepatol. 2015 Apr;62(4):848-54. doi: 10.1016/j.jhep.2014.11.005. Epub 2014 Nov 11.
10
Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.术前血清甲胎蛋白在肝细胞癌中的预后意义及其与临床病理因素的相关性:来自中国的单中心经验
Asian Pac J Cancer Prev. 2015;16(10):4421-7. doi: 10.7314/apjcp.2015.16.10.4421.

引用本文的文献

1
Key Enzymes in Pyrimidine Synthesis, CAD and CPS1, Predict Prognosis in Hepatocellular Carcinoma.嘧啶合成中的关键酶CAD和CPS1可预测肝细胞癌的预后。
Cancers (Basel). 2021 Feb 11;13(4):744. doi: 10.3390/cancers13040744.

本文引用的文献

1
Impact of PIVKA-II in diagnosis of hepatocellular carcinoma.异常凝血酶原在肝细胞癌诊断中的作用。
J Adv Res. 2013 Nov;4(6):539-46. doi: 10.1016/j.jare.2012.10.004. Epub 2013 Jan 11.
2
Outcomes and predictors of microvascular invasion of solitary hepatocellular carcinoma.单发肝细胞癌微血管侵犯的结果和预测因素。
Hepatol Res. 2014 Aug;44(8):846-53. doi: 10.1111/hepr.12196. Epub 2013 Aug 19.
3
Clinicopathologic characteristics of patients with non-B non-C hepatitis virus hepatocellular carcinoma after hepatectomy.非乙型肝炎病毒和非丙型肝炎病毒相关性肝细胞癌患者行肝切除术后的临床病理特征。
Am J Surg. 2012 Sep;204(3):300-7. doi: 10.1016/j.amjsurg.2011.11.014. Epub 2012 May 15.
4
A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma.钆塞酸二钠(Gd-EOB-DTPA)增强磁共振成像肝胆期非平滑肿瘤边缘预测肝细胞癌患者肝切除术后微血管门静脉侵犯、肝内转移和早期复发。
J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):575-85. doi: 10.1007/s00534-010-0369-y.
5
Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.深入了解肝癌肿瘤标志物脱γ-羧基凝血酶原的临床和分子特征。
Liver Int. 2011 Jan;31(1):22-35. doi: 10.1111/j.1478-3231.2010.02348.x. Epub 2010 Sep 27.
6
Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.肝癌切除术前行微血管侵犯预测。
J Surg Oncol. 2010 Oct 1;102(5):462-8. doi: 10.1002/jso.21631.
7
A review of the prognostic factors in patients with recurrence after liver resection for hepatocellular carcinoma.肝细胞癌肝切除术后复发患者的预后因素综述。
Am J Surg. 2007 Apr;193(4):431-7. doi: 10.1016/j.amjsurg.2006.06.041.
8
Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.甲胎蛋白和异常凝血酶原阳性状态:复发性肝细胞癌的重要预后因素。
World J Surg. 2004 Jul;28(7):702-7. doi: 10.1007/s00268-004-7205-y. Epub 2004 Jun 8.

术前肿瘤标志物梯度对预测肝细胞癌微血管侵犯的意义

Significance of a preoperative tumor marker gradient for predicting microvascular invasion in cases of hepatocellular carcinoma.

作者信息

Koizumi Satoshi, Yamashita Shingo, Matsumura Satoshi, Takeda Kazuhisa, Minagawa Takuya, Kobayashi Shinjiro, Hibi Taizo, Shinoda Masahiro, Endo Itaru, Tanabe Minoru, Yamamoto Masakazu, Otsubo Takehito

机构信息

Division of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa 216-8511, Japan.

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.

出版信息

Mol Clin Oncol. 2020 Mar;12(3):290-294. doi: 10.3892/mco.2020.1975. Epub 2020 Jan 10.

DOI:10.3892/mco.2020.1975
PMID:32064109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7016610/
Abstract

Although vascular invasion is an important factor in the progression and treatment of hepatocellular carcinoma (HCC), it remains difficult to determine, on the basis of preoperative imaging alone, whether vascular invasion, especially microvascular invasion, has occurred. The current retrospective study enrolled 292 patients who, between 2004 and 2014, underwent curative hepatectomy as an initial treatment for HCC. The patients were divided between those with (n=70) and those without (n=222) microvascular invasion. Whether tumor-marker-based prediction of microvascular invasion was possible was assessed by comparing the preoperative serum α-fetoprotein (AFP) and prothrombin induced by vitamin K absence or antagonist-II concentrations between two groups of patients. The AFP concentration was significantly higher in patients with microvascular invasion compared with patients without microvascular invasion (P=0.0019). Stepwise logistic regression analysis demonstrated the AFP concentration and the logarithmic conversion ratio of the AFP gradient (log AFP grad) to be useful (P=0.0019; 0.0424) for predicting microvascular invasion. The serum AFP concentration and log AFP grad appear to be clinically useful in predicting microvascular invasion in patients with HCC.

摘要

尽管血管侵犯是肝细胞癌(HCC)进展和治疗的一个重要因素,但仅根据术前影像学检查仍难以确定是否发生了血管侵犯,尤其是微血管侵犯。本项回顾性研究纳入了292例在2004年至2014年间接受根治性肝切除术作为HCC初始治疗的患者。这些患者被分为有微血管侵犯(n = 70)和无微血管侵犯(n = 222)两组。通过比较两组患者术前血清甲胎蛋白(AFP)和维生素K缺乏或拮抗剂-II诱导的凝血酶原浓度,评估基于肿瘤标志物预测微血管侵犯是否可行。与无微血管侵犯的患者相比,有微血管侵犯的患者AFP浓度显著更高(P = 0.0019)。逐步逻辑回归分析表明,AFP浓度和AFP梯度的对数转换率(log AFP grad)对预测微血管侵犯有用(P = 0.0019;0.0424)。血清AFP浓度和log AFP grad在预测HCC患者微血管侵犯方面似乎具有临床实用性。